The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s epinephrine market report forecasts the epinephrine market size to grow to $3.49 Billion by 2027, with a CAGR (compound annual growth rate) of more than 9%.

Learn More On The Epinephrine Market Report 2023 – https://www.thebusinessresearchcompany.com/report/epinephrine-global-market-report

Epinephrine Market Size Forecast
The global epinephrine market is expected to grow from $2.20 billion in 2022 to $2.44 billion in 2023 at a compound annual growth rate (CAGR) of 11%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global epinephrine market size is expected to reach $3.49 billion in 2027 at a CAGR of 9.4%.

North America held the largest epinephrine market share.

Key Epinephrine Market Driver ­– Increase In The Prevalence Of Chronic Respiratory Diseases
According to data published by The Pan American Health Organisation (PAHO) in 2020, a specialised UN body in charge of fostering global health cooperation in the Americas, respiratory disease deaths in the United States increased from 38.9 deaths per 1 million population in 2018 to 39.1 deaths per 1 million population in 2019. The need for epinephrine is projected to rise as the prevalence of chronic respiratory disorders rises.

Request for A Sample Of The Global Epinephrine Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9967&type=smp

Key Epinephrine Market Trend – Product Innovation
To increase convenience of consumption and maintain their market position, major firms in the epinephrine market are introducing new and better sophisticated products, such as auto-injectors or advanced injections. After receiving FDA approval, Baxter International Inc., a US-based healthcare firm, will offer Premix Norepinephrine Bitartrate in 5% Dextrose Injection (norepinephrine) in September 2021. Norepinephrine bitartrate is a convenient formulation of norepinephrine available in quantities of 4 mg/250 mL (16 mcg/mL) and 8 mg/250 mL (32 mcg/mL) from the pharmaceutical business. Adults with severe, acute hypotension are given norepinephrine to raise their blood pressure.

Epinephrine Market Segment
1) By Type: Prefilled Syringe, Auto-injector, Ampoules and Vials
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
3) By Application: Anaphylaxis, Cardiac Arrest, Superficial Bleeding, Respiratory Disorders, Other Applications

Epinephrine Market Major Players and Strategies
Major players in the epinephrine market are ALK-Abelló A/S, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Amneal Pharmaceuticals Inc., Bausch Health Companies Inc., Abbott Laboratories, Sanofi S.A., Viatris Inc., Lincoln Medical Ltd., Kaleo Inc., Gland Pharma Limited, Adamis Pharmaceuticals Corporation, Harvest Pharmaceuticals Inc., and Merit Pharmaceutical.

Marathon Asset Management, LP, a US-based investment management firm, paid $310 million for Kaléo in November 2021. This acquisition is a strategic fit for Kaléo’s growth of services in supporting patients at risk of anaphylaxis and other critical and life-threatening diseases, using Marathon’s experienced allergist management team. Kaléo is a pharmaceutical firm established in the United States that specialises in new healthcare products such as epinephrine injections.

The Epinephrine Global Market Report 2023 covers regional data on epinephrine market size, epinephrine market trends and drivers, opportunities, strategies, and epinephrine market competitor analysis. The countries covered in the epinephrine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Epinephrine, commonly known as adrenaline, is a hormone and neurotransmitter that is used to treat life-threatening allergic responses caused by foods, drugs, latex, insect bites or stings, and other reactions that are treated with epinephrine injections in conjunction with emergency medical therapy.

View More Reports Related To The Epinephrine Market –
Antidepressants Global Market Report 2023
Bipolar Disorder Therapeutics Global Market Report 2023
Antiemetics And Antinauseants Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: